Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

Within Diabetes Care, the company is driving robust growth through its flagship, sensor-based CGM ... 2 users. Of late, ABT is fast gaining momentum, leveraging consistent upgrades of FreeStyle Libre.

Omnipod 5 is now available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensor compatibility. Indicated for individuals aged two years and older ...

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant ...

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant step forward ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Abbott, Dexcom agree to 10-year truce over diabetes sensor ... its Libre Rio and Lingo CGM systems, both the company’s first to become available without a prescription. Based on its FreeStyle ...

The FreeStyle Libre 3 reader with the sensor and smartphone. [Image courtesy of Abbott ... including the FreeStyle Libre continuous glucose monitor (CGM), Navitor heart valve, TriClip valve repair ...